ARTICLE | Clinical News
Isavuconazole: Phase III
July 29, 2013 7:00 AM UTC
Basilea completed enrollment of 150 patients with pre-existing renal impairment or with invasive fungal disease in the open-label, international Phase III VITAL trial evaluating 200 mg IV or oral isav...